How Astrazeneca became the London Stock Exchange’s first £200bn company

Astrazeneca has become the first UK-listed company to achieve a market valuation of £200bn, a landmark achievement for both the pharmaceutical giant and the London Stock Exchange, as investors have been won over by its ambition and success with cancer treatments. The company’s shares rose by 1.1 per cent on Tuesday, propelling its market capitalisation [...]